Roger Perlmutter

Roger Perlmutter

Amministratore Delegato presso EIKON THERAPEUTICS, INC.

Patrimonio netto: 18 M $ in data 31/08/2026

73 anni
Health Technology
Commercial Services
Consumer Services

Profilo

Dr. Roger M.
Perlmutter
is an Independent Director at NGM Biopharmaceuticals, Inc., a Chairman & Chief Executive Officer at Eikon Therapeutics, Inc., an Independent Director at Insitro, Inc., a Chairman at The Reed Institute, a Member at American Academy of Arts & Sciences and a Science Partner at The Column Group LLC.
He is on the Board of Directors at NGM Biopharmaceuticals, Inc., Insitro, Inc., Exonics Therapeutics, Inc. and Institute for Systems Biology.
Dr. Perlmutter was previously employed as an Executive Vice President by Merck & Co., Inc., an Independent Director by Ablynx NV, a Non-Executive Director by Nxera Pharma UK Ltd., an Executive VP & Head-Research & Development by Amgen, Inc., an Independent Director by StemCells, Inc., a Non-Executive Director by Merck Research Laboratories Massachusetts LLC, an EVP-Worldwide Basic & Preclinical Research by Merck & Co., Inc., a Chairman-Immunology Department & Professor by University of Washington, a President & Director by Alantos Pharmaceuticals Holding, Inc., and a President by The American Association of Immunologists.
He also served on the board at Immune Design Corp.
and The Irvington Institute for Immunological Research.
He received his undergraduate degree from The Reed Institute and a doctorate degree from Washington University in St. Louis.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
02/03/2026 1.760.713 ( 3,25% ) 18 M $ 31/08/2026

Posizioni attive di Roger Perlmutter

SocietàPosizioneInizio
EIKON THERAPEUTICS, INC. Amministratore Delegato 01/05/2021
NGM BIOPHARMACEUTICALS, INC. Direttore/Membro del Consiglio 08/06/2021
Direttore/Membro del Consiglio 01/10/2020
Direttore/Membro del Consiglio 30/01/2018
Corporate Officer/Principal -
Presidente 21/06/2012
Direttore/Membro del Consiglio 24/05/2013
Corporate Officer/Principal -

Precedenti posizioni note di Roger Perlmutter

SocietàPosizioneFine
Presidente 01/01/2021
░░░░░ ░░░░░ ░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
░░░░░░░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Roger Perlmutter

Formazione di Roger Perlmutter

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

96

Relazioni di 1° grado

20

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private20

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Consumer Services

Consumer Services

Health Technology

Commercial Services

Commercial Services

Health Technology

Commercial Services

Commercial Services

Health Technology

Finance

Health Technology

Health Technology

Health Technology

Health Technology

  1. Mercati
  2. Insiders
  3. Roger Perlmutter